Home Online Features MAXONA PHARMACEUTICALS GRANTED FIFTH PATENT FOR FIRST TO MARKET PRODUCT MAX-001
MAXONA PHARMACEUTICALS GRANTED FIFTH PATENT FOR FIRST TO MARKET PRODUCT MAX-001
Hand-out
Press Releases
Maxona Pharmaceuticals  
February 25, 2025

MAXONA PHARMACEUTICALS GRANTED FIFTH PATENT FOR FIRST TO MARKET PRODUCT MAX-001

MAX-001 is a Non-Opioid, Non-NSAID Oral Therapy in Development for Treatment of Acute and Chronic Pain

logo salamanca press

Salamanca Press

email salamanca press
Local & Social